Mike Evers, Author at ORTHOWORLD

Stryker and Zimmer Biomet Kick Off 2025 with Strategic Moves

Stryker divested the majority of its spinal implant business while Zimmer Biomet agreed to acquire foot-and-ankle player Paragon 28.

Jan 30, 2025

The company's orthopedic sales grew in the high single digits in 2024, driven by new products and healthy procedure demand.

Jan 30, 2025

The company's orthopedic business grew in the low-single-digits in 2024 as it faced restructuring and competitive headwinds.

Jan 24, 2025

In this video, we take a look at three things we might learn during company earnings reports for the fourth quarter of 2024.

Jan 20, 2025

The top four players in spine are fully invested in enabling technology and are changing the competitive dynamics of the segment.

Jan 15, 2025

Earnings season for 4Q24 is still a few weeks away, so let’s look ahead to 2025 and our expectations for orthopedics’ top players.

Jan 10, 2025

The largest joint replacement companies are averaging double-digit knee replacement sales growth outside the U.S. over the last two years.

Dec 10, 2024

In this video, we discuss the orthopedic market's 2024 performance and the tailwinds that could lead to sustained higher growth.

Dec 04, 2024

Executives from the top orthopedic companies discuss procedure volumes, VBP impact and the footprint of robotics.

Dec 03, 2024

We examine the 2024 performance of three companies among the fastest-growing in orthopedics: Treace Medical, Paragon 28 and OrthoPediatrics.

Nov 18, 2024